Gilead Sciences
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
Break Gilead’s patent since US has bought all stock of Remdesivir
Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far
US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug
Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.
- UN Security Council agrees to extend aid to rebel-held regions of Syria for six months
- Bolsonaro supporter murders Workers’ Party member at birthday party
- Uncertainty prevails in Sri Lanka as protesters wait for president, PM to quit
- Saudi forces violate ceasefire in Yemen, killing 17
- Bid to ‘normalize’ relations with Bulgaria sparks protest in North Macedonia
